Equities

STERIS plc

STERIS plc

Actions
  • Price (EUR)207.80
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+21.56%
  • Beta--
Data delayed at least 15 minutes, as of Mar 28 2024 07:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

STERIS plc is a provider of products and services that support patient care with an emphasis on infection prevention. The Company’s segments include Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. The Healthcare segment is focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. Its Applied Sterilization Technologies (AST) segment is a third-party service provider for contract sterilization, as well as testing services needed to validate sterility services for medical device and pharmaceutical manufacturers. Its Life Sciences segment provides a comprehensive offering of products and services that support pharmaceutical manufacturing, primarily for vaccine and other biopharma customers focused on aseptic manufacturing. Its Dental segment provides a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems.

  • Revenue in USD (TTM)5.41bn
  • Net income in USD566.84m
  • Incorporated2016
  • Employees17.00k
  • Location
    STERIS plcBlock a Riverside IV70 Sir John Rogerson's QuayDUBLIN 2IrelandIRL
  • Phone+353 12322000
  • Websitehttps://www.steris.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
STE:NYQ since
announced
Transaction
value
Becton Dickinson & Co-Surgical Instrumentation AssetsDeal completed20 Jun 202320 Jun 2023Deal completed5.31%540.00m
Data delayed at least 15 minutes, as of Mar 28 2024 16:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.